These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 2786857)
1. Methyl-acetylenicputrescine (MAP), an inhibitor of polyamine biosynthesis, reduces the frequency and cytolytic activity of alloantigen-induced LyT 2.2 positive lymphocytes in vivo. Bowlin TL; McKown BJ; Schroeder KK Int J Immunopharmacol; 1989; 11(3):259-65. PubMed ID: 2786857 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of alloantigen-induced cytolytic T lymphocytes in vitro with (2R,5R)-6-heptyne-2,5-diamine, an irreversible inhibitor of ornithine decarboxylase. Bowlin TL; Davis GF; McKown BJ Cell Immunol; 1988 Feb; 111(2):443-50. PubMed ID: 3123076 [TBL] [Abstract][Full Text] [Related]
3. Increased ornithine decarboxylase activity and polyamine biosynthesis are required for optimal cytolytic T lymphocyte induction. Bowlin TL; McKown BJ; Sunkara PS Cell Immunol; 1987 Mar; 105(1):110-7. PubMed ID: 3102080 [TBL] [Abstract][Full Text] [Related]
4. Immunosuppressive effects of (2R,5R)-6-heptyne-2,5-diamine an inhibitor of polyamine synthesis: I. Effects on mitogen-induced immunoglobulin production in human cultured lymphocytes. Pasquali JL; Mamont PS; Weryha A; Knapp AM; Blervaque A; Siat M Clin Exp Immunol; 1988 Apr; 72(1):141-4. PubMed ID: 3396214 [TBL] [Abstract][Full Text] [Related]
5. Methylacetylenic putrescine (MAP), an inhibitor of polyamine biosynthesis, prevents the development of collagen-induced arthritis. Wolos JA; Logan DE; Bowlin TL Cell Immunol; 1990 Feb; 125(2):498-507. PubMed ID: 2297795 [TBL] [Abstract][Full Text] [Related]
6. Alpha-difluoromethylornithine, an inhibitor of polyamine biosynthesis, augments cyclosporin A inhibition of cytolytic T lymphocyte induction. Bowlin TL; Rosenberger AL; McKown BJ Clin Exp Immunol; 1989 Jul; 77(1):151-6. PubMed ID: 2504519 [TBL] [Abstract][Full Text] [Related]
7. Effects of three irreversible inhibitors of ornithine decarboxylase on macrophage-mediated tumoricidal activity and antitumor activity in B16F1 tumor-bearing mice. Bowlin TL; Hoeper BJ; Rosenberger AL; Davis GF; Sunkara PS Cancer Res; 1990 Aug; 50(15):4510-4. PubMed ID: 2114941 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of cytolytic T lymphocyte maturation with ornithine, arginine, and putrescine. Susskind BM; Chandrasekaran J J Immunol; 1987 Aug; 139(3):905-12. PubMed ID: 2955052 [TBL] [Abstract][Full Text] [Related]
9. The mechanism of antigen presentation by dendritic cells and splenic adherent cells in the induction of an allogeneic cytotoxic T-lymphocyte response to H-2Kk liposomes. Greenstein JL; Herrmann SH; Sunshine GH; Burakoff SJ Cell Immunol; 1986 Jul; 100(2):389-99. PubMed ID: 2944605 [TBL] [Abstract][Full Text] [Related]
10. Role of cytotoxic T lymphocytes in the prevention of lupus-like disease occurring in a murine model of graft-vs-host disease. Via CS; Sharrow SO; Shearer GM J Immunol; 1987 Sep; 139(6):1840-9. PubMed ID: 2957440 [TBL] [Abstract][Full Text] [Related]
11. Immunosuppressive effects of (2R,5R)-6-heptyne-2,5-diamine, an inhibitor of polyamine synthesis: II. Beneficial effects on the development of a lupus-like disease in MRL-lpr/lpr mice. Claverie N; Pasquali JL; Mamont PS; Danzin C; Weil-Bousson M; Siat M Clin Exp Immunol; 1988 May; 72(2):293-8. PubMed ID: 3409547 [TBL] [Abstract][Full Text] [Related]
12. Restoration of the polyamine contents in rat hepatoma tissue-culture cells after inhibition of polyamine biosynthesis. Relationship with cell proliferation. Gerner EW; Mamont PS Eur J Biochem; 1986 Apr; 156(1):31-5. PubMed ID: 3082634 [TBL] [Abstract][Full Text] [Related]
13. Comparison of the biological effects of four irreversible inhibitors of ornithine decarboxylase in two murine lymphocytic leukemia cell lines. Pera PJ; Kramer DL; Sufrin JR; Porter CW Cancer Res; 1986 Mar; 46(3):1148-54. PubMed ID: 3080234 [TBL] [Abstract][Full Text] [Related]
14. Effect of FK506 treatment on allocytolytic T lymphocyte induction in vivo: differential effects of FK506 on L3T4+ and Ly2+ T cells. Maruyama M; Suzuki H; Yamashita N; Yano S Transplantation; 1990 Aug; 50(2):272-7. PubMed ID: 1696410 [TBL] [Abstract][Full Text] [Related]
15. The glycosphingolipid globoside as a serological marker on cytolytic T lymphocyte precursors and alloantigen-responsive proliferating T lymphocytes in murine spleen. Mühlradt PF; Bethke U; Monner DA; Petzoldt K Eur J Immunol; 1984 Sep; 14(9):852-8. PubMed ID: 6236992 [TBL] [Abstract][Full Text] [Related]
16. Suppression of alloimmune cytotoxic T lymphocyte (CTL) generation by depletion of NK cells and restoration by interferon and/or interleukin 2. Suzuki R; Suzuki S; Ebina N; Kumagai K J Immunol; 1985 Apr; 134(4):2139-48. PubMed ID: 2579129 [TBL] [Abstract][Full Text] [Related]
17. T helper cells in cytotoxic T lymphocyte development: analysis of the cellular basis for deficient T helper cell function in the L3T4-independent T helper cell pathway. Ciavarra RP Cell Immunol; 1991 May; 134(2):427-41. PubMed ID: 1850663 [TBL] [Abstract][Full Text] [Related]
18. Cytolytic T lymphocyte clones that proliferate autonomously to specific alloantigenic stimulation. II. Relationship of the Lyt-2 molecular complex to cytolytic activity, proliferation, and lymphokine secretion. Glasebrook AL; Kelso A; MacDonald HR J Immunol; 1983 Apr; 130(4):1545-51. PubMed ID: 6187814 [TBL] [Abstract][Full Text] [Related]
19. T-cell responses induced by the parenteral injection of antigen-modified syngeneic cells. II. Mechanisms, specificity, and cellular analysis of 2,4,6-trinitrophenol (TNP)-specific cytolytic response priming by intravenous versus subcutaneous injection with TNP-modified syngeneic cells. Miller SD; Butler LD; Cleveland RP; Moorhead JW; Claman HN; Chiller JC Cell Immunol; 1983 Dec; 82(2):378-93. PubMed ID: 6197193 [TBL] [Abstract][Full Text] [Related]
20. Regulation of the cytotoxic activity of alloreactive cytotoxic T lymphocytes by helper cells and lymphokines. Ting CC; Loh NN; Hargrove ME Cell Immunol; 1986 Sep; 101(2):299-311. PubMed ID: 2944608 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]